| Literature DB >> 25379557 |
Jason L Muesse1, Shanda H Blackmon2, Warren A Ellsworth3, Min P Kim2.
Abstract
The objective of this study was to evaluate the efficacy of various treatment options for sternoclavicular joint osteomyelitis. We evaluated patients with a diagnosis of sternoclavicular joint osteomyelitis, treated at our hospital from 2002 to 2012. Four treatment options were compared. Three out of twelve patients were successfully cured with antibiotics alone (25%). Debridement with or without negative pressure therapy was successful for one of three patients (33%). Simultaneous debridement, bone resection, and muscle flap coverage of the acquired defect successfully treated one of two patients (50%). Debridement with delayed bone resection and muscle flap coverage was successful in five of five patients (100%). Osteomyelitis of the sternoclavicular joint is a rare disease that has become more prevalent in recent years and can be associated with increasing use of long-term indwelling catheters. Initial debridement with delayed bone resection and pectoralis major muscle flap coverage can effectively treat sternoclavicular joint osteomyelitis.Entities:
Year: 2014 PMID: 25379557 PMCID: PMC4208504 DOI: 10.1155/2014/747315
Source DB: PubMed Journal: Surg Res Pract ISSN: 2356-6124
Figure 1(a) Computerized Tomography scan demonstrating left sternoclavicular joint abscess and osteomyelitis in 57-year-old male with a history of infected tunneled hemodialysis catheter (removed). (b) Photograph demonstrating wound 3 weeks after incision and debridement, before resection of infected bony structures. (c) Photograph demonstrating surgically acquired defect of chest wall following resection of infected bony structures. (d) Photograph demonstrating mobilization of left pectoralis major muscle flap being advanced into surgically acquired defect of chest wall.
Patient and sternoclavicular joint osteomyelitis characteristics.
|
| |
|---|---|
| Age, (y) mean ± SD | 58 ± 11 |
| Male, | 8 (67) |
| Ethnicity, | |
| Caucasian | 7 (58) |
| African American | 1 (8) |
| Hispanic | 4 (33) |
|
| |
|
| |
|
| |
| Comorbidities, | |
| HTN | 8 (73) |
| BMI > 30 | 7 (64) |
| DM | 6 (55) |
| Smoker | 5 (45) |
| CAD | 4 (36) |
| Sleep apnea | 4 (36) |
| Hyperlipidemia | 4 (36) |
| Cancer | 3 (27) |
| ESRD | 2 (18) |
| CVA | 2 (18) |
|
| |
|
| |
|
| |
| Cause, | |
| Catheter | 7 (58) |
| Infection at distant site | 1 (8) |
| Skin biopsy | 1 (8) |
| Unknown | 3 (25) |
|
| |
|
| |
|
| |
| Organism, | |
|
| 8 (67) |
|
| 2 (17) |
| Group B | 1 (8) |
|
| 1 (8) |
BMIL: body mass index; CAD: coronary artery disease; CVA: history of cerebrovascular accident (stroke); DM: diabetes mellitus; ESRD: end-stage renal disease; HTN: hypertension; n: number of patients; SD: standard deviation.
Efficacy of treatment.
| Success rate | |
|---|---|
| Abx ( | 3 (25) |
| I & D ( | 1 (33) |
| Imm flap ( | 1 (50) |
| Delay flap ( | 5 (100) |
Abx: antibiotics alone; Delay flap: incision and debridement with delayed bone resection and muscle flap advancement; I & D: incision and debridement, Imm flap: incision and debridement with bone resection and immediate muscle flap advancement.
Figure 2Algorithm of treatment of sternoclavicular joint osteomyelitis. Patients should be initially treated with systemic antibiotics. When there is progression of disease despite antibiotic treatment, the patient should undergo initial debridement and subsequent negative pressure therapy. If the patient is medically stable, then after two to three weeks the patient should have formal resection and muscle flap coverage.